Drug Profile
Cisplatin oral - Ethypharm
Alternative Names: CP - Ethypharm; Drugsol; Oral cisplatin - EthypharmLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Ethypharm
- Class Antineoplastics; Platinum complexes; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 18 Jul 2006 No development reported - Phase-I for Cancer in France (PO)
- 27 Jun 2001 Phase-I clinical trials for Cancer in France (PO)